ADX-097

· Q32 Bio Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ADX-097, covering 2025-04-20 to 2025-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G [Phase 2]

See pricing